Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

We conducted a large population-based survey of fragile X (FRAXA) syndrome in ethnically diverse metropolitan Atlanta. The eligible study population consisted of public school children, aged 7-10 years, in special education-needs (SEN) classes. The purpose of the study was to estimate the prevalence among whites and, for the first time, African Americans, among a non-clinically referred population. At present, 5 males with FRAXA syndrome (4 whites and 1 African American), among 1,979 tested males, and no females, among 872 tested females, were identified. All males with FRAXA syndrome were mentally retarded and had been diagnosed previously. The prevalence for FRAXA syndrome was estimated to be 1/3,460 (confidence interval [CI] 1/7,143-1/1,742) for the general white male population and 1/4, 048 (CI 1/16,260-1/1,244) for the general African American male population. We also compared the frequency of intermediate and premutation FRAXA alleles (41-199 repeats) and fragile XE syndrome alleles (31-199 repeats) in the SEN population with that in a control population, to determine if there was a possible phenotype consequence of such high-repeat alleles, as has been reported previously. No difference was observed between our case and control populations, and no difference was observed between populations when the probands were grouped by a rough estimate of IQ based on class placement. These results suggest that there is no phenotype consequence of larger alleles that would cause carriers to be placed in an SEN class.

[1]  A. Vianna-Morgante,et al.  Fully mutated and gray-zone FRAXA alleles in Brazilian mentally retarded boys. , 1999, American journal of medical genetics.

[2]  W. Brown,et al.  Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. , 1999, American journal of medical genetics.

[3]  P. Jacobs,et al.  Studies of FRAXA and FRAXE in women with premature ovarian failure. , 1998, Journal of medical genetics.

[4]  T. Cooper,et al.  Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.

[5]  P. Jacobs,et al.  Fragile X premutation screening in women with premature ovarian failure. , 1998, Human reproduction.

[6]  B. Simon‐Bouy,et al.  The intermediate alleles of the fragile X CGG repeat in patients with mental retardation , 1998, Clinical genetics.

[7]  C. Beldjord,et al.  Prevalence of fragile-X syndrome and FRAXE among children with intellectual disability in a Caribbean island, Guadeloupe, French West Indies. , 1998, Journal of intellectual disability research : JIDR.

[8]  N. Morton,et al.  FRAXA and FRAXE: evidence against segregation distortion and for an effect of intermediate alleles on learning disability. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Reiss,et al.  The FMR1 and FMR2 Mutations Are Not Common Etiologies of Academic Difficulty Among School-Age Children , 1997, Journal of developmental and behavioral pediatrics : JDBP.

[10]  K. Pavelić,et al.  Expand Long PCR for fragile X mutation detection , 1997, Clinical genetics.

[11]  Ben A. Oostra,et al.  Screening and Diagnosis for the Fragile X Syndrome among the Mentally Retarded: An Epidemiological and Psychological Survey , 1997 .

[12]  T. Jenkins,et al.  Fragile X syndrome occurs in the South African black population. , 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[13]  E. Haan,et al.  FMR2 expression in families with FRAXE mental retardation. , 1997, Human molecular genetics.

[14]  J. Morton,et al.  Fragile X syndrome is less common than previously estimated. , 1997, Journal of medical genetics.

[15]  C. Mathew,et al.  Clinical, cytogenetic, and molecular analysis of three families with FRAXE. , 1997, Journal of medical genetics.

[16]  W. Brown,et al.  Familial transmission of the FMR1 CGG repeat. , 1996, American journal of human genetics.

[17]  S. Knight,et al.  Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males. , 1996, American journal of human genetics.

[18]  S. Sherman,et al.  Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. , 1996, American journal of medical genetics.

[19]  D. Chitayat,et al.  Tissue-specific methylation differences and cognitive function in fragile X premutation females. , 1996, American journal of medical genetics.

[20]  M. Hautzinger,et al.  Fragile-X carrier females: evidence for a distinct psychopathological phenotype? , 1996, American journal of medical genetics.

[21]  W. Brown,et al.  A survey of FRAXE allele sizes in three populations. , 1996, American journal of medical genetics.

[22]  M. Partington,et al.  Confirmation of early menopause in fragile X carriers. , 1996, American journal of medical genetics.

[23]  D. Bick,et al.  Molecular fragile X screening in normal populations. , 1996, American journal of medical genetics.

[24]  P. Jacobs,et al.  Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. , 1996, Human molecular genetics.

[25]  W. Brown.  The FRAXE Syndrome: is it time for routine screening? , 1996, American journal of human genetics.

[26]  K. Davies,et al.  A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom. , 1996, American journal of human genetics.

[27]  W. Doerfler,et al.  Purification of Nuclear Proteins from Human HeLa Cells That Bind Specifically to the Unstable Tandem Repeat (CGG) in the Human FMR1 Gene (*) , 1996, The Journal of Biological Chemistry.

[28]  S. Sherman,et al.  Population dynamics of a meiotic/mitotic expansion model for the fragile X syndrome. , 1995, American journal of human genetics.

[29]  É. Khandjian,et al.  Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. , 1995, American journal of human genetics.

[30]  S. Sherman.  The high prevalence of fragile X premutation carrier females: is this frequency unique to the French Canadian population? , 1995, American journal of human genetics.

[31]  A. Chudley,et al.  Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots. , 1995, Biochemical and molecular medicine.

[32]  M. Bamshad,et al.  Population genetics of trinucleotide repeat polymorphisms. , 1995, Human molecular genetics.

[33]  P. Jacobs,et al.  Fragile X premutations in familial premature ovarian failure , 1995, The Lancet.

[34]  N. Morton,et al.  Evolutionary dynamics of the FMR1 locus , 1995, Annals of Human Genetics.

[35]  N. Morton,et al.  An n-allele model for progressive amplification in the FMR1 locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Gravholt,et al.  Quantitative comparison of FMR1 gene expression in normal and premutation alleles. , 1995 .

[37]  D. Loesch,et al.  FRAXE and mental retardation. , 1995, Journal of medical genetics.

[38]  K. Davies,et al.  Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. , 1994, American journal of human genetics.

[39]  C. Mathew,et al.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. , 1994, American journal of human genetics.

[40]  K. Kolehmainen,et al.  Population genetics of fragile X: a multiple allele model with variable risk of CGG repeat expansion. , 1994, American journal of medical genetics.

[41]  D. Loesch,et al.  Transmitting males and carrier females in fragile X--revisited. , 1994, American journal of medical genetics.

[42]  R. Stevenson,et al.  Obstetrical and gynecological complications in fragile X carriers: a multicenter study. , 1994, American journal of medical genetics.

[43]  S. Warren,et al.  Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles , 1994, Cell.

[44]  W. Brown,et al.  Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. , 1994, JAMA.

[45]  M. Ramsay,et al.  Absence of myotonic dystrophy in southern African Negroids is associated with a significantly lower number of CTG trinucleotide repeats. , 1994, Journal of medical genetics.

[46]  R. Hagerman,et al.  A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome. , 1993, American journal of diseases of children.

[47]  S. Warren,et al.  FMR1 protein: conserved RNP family domains and selective RNA binding. , 1993, Science.

[48]  W. Brown,et al.  Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. , 1993, American journal of human genetics.

[49]  B. Pennington,et al.  The Neurocognitive Phenotype of Female Carriers of Fragile X: Additional Evidence for Specificity , 1993, Journal of developmental and behavioral pediatrics : JDBP.

[50]  K. Davies,et al.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation , 1993, Cell.

[51]  A. Reiss,et al.  Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. , 1993, American journal of human genetics.

[52]  K. Davies,et al.  Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. , 1993, Journal of medical genetics.

[53]  R. Hagerman.  Annotation: fragile X syndrome: advances and controversy. , 1992, Journal of child psychology and psychiatry, and allied disciplines.

[54]  J. Sutcliffe,et al.  DNA methylation represses FMR-1 transcription in fragile X syndrome. , 1992, Human molecular genetics.

[55]  N. Morton,et al.  Population genetics of the fragile-X syndrome: multiallelic model for the FMR1 locus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  G. Sutherland,et al.  Characterisation of a new rare fragile site easily confused with the fragile X. , 1992, Human molecular genetics.

[57]  P. Jacobs,et al.  Two families with Xq27.3 fragility, no detectable insert in the FMR-1 gene, mild mental impairment, and absence of the Martin-Bell phenotype. , 1992, American journal of medical genetics.

[58]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[59]  T. Ashizawa,et al.  Ethnic distribution of myotonic dystrophy gene , 1991, The Lancet.

[60]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[61]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[62]  T. Webb,et al.  Prevalence of fragile X syndrome. , 1991, American journal of medical genetics.

[63]  R. Hagerman,et al.  Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. , 1991, American journal of medical genetics.

[64]  R. Hagerman,et al.  Fragile X checklist. , 1991, American journal of medical genetics.

[65]  J. Sved,et al.  Population genetic consequences of the fragile-X syndrome, based on the X-inactivation imprinting model. , 1990, American journal of human genetics.

[66]  Frank J. Bernieri,et al.  Growing up and growing apart: a developmental meta-analysis of twin studies. , 1990, Psychological bulletin.

[67]  P. Wolff,et al.  Variable expression of the fragile X syndrome in heterozygous females of normal intelligence. , 1988, American journal of medical genetics.

[68]  V. Pa,et al.  Cytogenetic abnormalities including the marker X chromosome in patients with severe mental retardation. , 1982 .

[69]  P. Venter,et al.  A marker X chromosome associated with nonspecific male mental retardation. The first South African cases. , 1981, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[70]  P. Howard-Peebles,et al.  Race distribution in X-linked mental retardation with macro-orchidism and fragile site in Xq. , 1980, American journal of human genetics.

[71]  W. Conover.  Statistical Methods for Rates and Proportions , 1974 .

[72]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[73]  P. Patsalis,et al.  FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population , 1998, Genetic epidemiology.

[74]  Asma N. Cheema,et al.  Phenotypic involvement in females with the FMR1 gene mutation. , 1998, American journal of mental retardation : AJMR.

[75]  S. Sherman.  Modeling the natural history of the fragile X gene , 1995 .

[76]  S. Warren,et al.  Quantitative comparison of FMR1 gene expression in normal and premutation alleles. , 1995, American journal of human genetics.

[77]  Silverman,et al.  Fragile X Syndrome Diagnosis Treatment And Research , 2016 .

[78]  P. Venter,et al.  Cytogenetic abnormalities including the marker X chromosome in patients with severe mental retardation. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[79]  J. Thoday.  Population Genetics , 1956, Nature.